<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="en" xml:lang="en"><head>

<meta charset="utf-8">
<meta name="generator" content="quarto-1.2.269">

<meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes">


<title>talks - Esophageal Cancer Treatment Decisions</title>
<style>
code{white-space: pre-wrap;}
span.smallcaps{font-variant: small-caps;}
div.columns{display: flex; gap: min(4vw, 1.5em);}
div.column{flex: auto; overflow-x: auto;}
div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
ul.task-list{list-style: none;}
ul.task-list li input[type="checkbox"] {
  width: 0.8em;
  margin: 0 0.8em 0.2em -1.6em;
  vertical-align: middle;
}
div.csl-bib-body { }
div.csl-entry {
  clear: both;
}
.hanging div.csl-entry {
  margin-left:2em;
  text-indent:-2em;
}
div.csl-left-margin {
  min-width:2em;
  float:left;
}
div.csl-right-inline {
  margin-left:2em;
  padding-left:1em;
}
div.csl-indent {
  margin-left: 2em;
}
</style>


<script src="site_libs/quarto-nav/quarto-nav.js"></script>
<script src="site_libs/quarto-nav/headroom.min.js"></script>
<script src="site_libs/clipboard/clipboard.min.js"></script>
<script src="site_libs/quarto-search/autocomplete.umd.js"></script>
<script src="site_libs/quarto-search/fuse.min.js"></script>
<script src="site_libs/quarto-search/quarto-search.js"></script>
<meta name="quarto:offset" content="./">
<script src="site_libs/quarto-html/quarto.js"></script>
<script src="site_libs/quarto-html/popper.min.js"></script>
<script src="site_libs/quarto-html/tippy.umd.min.js"></script>
<script src="site_libs/quarto-html/anchor.min.js"></script>
<link href="site_libs/quarto-html/tippy.css" rel="stylesheet">
<link href="site_libs/quarto-html/quarto-syntax-highlighting.css" rel="stylesheet" id="quarto-text-highlighting-styles">
<script src="site_libs/bootstrap/bootstrap.min.js"></script>
<link href="site_libs/bootstrap/bootstrap-icons.css" rel="stylesheet">
<link href="site_libs/bootstrap/bootstrap.min.css" rel="stylesheet" id="quarto-bootstrap" data-mode="light">
<script id="quarto-search-options" type="application/json">{
  "location": "navbar",
  "copy-button": false,
  "collapse-after": 3,
  "panel-placement": "end",
  "type": "overlay",
  "limit": 20,
  "language": {
    "search-no-results-text": "No results",
    "search-matching-documents-text": "matching documents",
    "search-copy-link-title": "Copy link to search",
    "search-hide-matches-text": "Hide additional matches",
    "search-more-match-text": "more match in this document",
    "search-more-matches-text": "more matches in this document",
    "search-clear-button-title": "Clear",
    "search-detached-cancel-button-title": "Cancel",
    "search-submit-button-title": "Submit"
  }
}</script>


<link rel="stylesheet" href="styles.css">
</head>

<body class="nav-fixed">

<div id="quarto-search-results"></div>
  <header id="quarto-header" class="headroom fixed-top">
    <nav class="navbar navbar-expand-lg navbar-dark ">
      <div class="navbar-container container-fluid">
      <div class="navbar-brand-container">
    <a class="navbar-brand" href="./index.html">
    <span class="navbar-title">talks</span>
    </a>
  </div>
          <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbarCollapse" aria-controls="navbarCollapse" aria-expanded="false" aria-label="Toggle navigation" onclick="if (window.quartoToggleHeadroom) { window.quartoToggleHeadroom(); }">
  <span class="navbar-toggler-icon"></span>
</button>
          <div class="collapse navbar-collapse" id="navbarCollapse">
            <ul class="navbar-nav navbar-nav-scroll me-auto">
  <li class="nav-item">
    <a class="nav-link" href="./index.html">
 <span class="menu-text">Home</span></a>
  </li>  
  <li class="dropdown-header">
 <span class="menu-text">about.qmd</span></li>
</ul>
              <div id="quarto-search" class="" title="Search"></div>
          </div> <!-- /navcollapse -->
      </div> <!-- /container-fluid -->
    </nav>
</header>
<!-- content -->
<div id="quarto-content" class="quarto-container page-columns page-rows-contents page-layout-article page-navbar">
<!-- sidebar -->
<!-- margin-sidebar -->
    <div id="quarto-margin-sidebar" class="sidebar margin-sidebar">
        <nav id="TOC" role="doc-toc" class="toc-active">
    <h2 id="toc-title">On this page</h2>
   
  <ul>
  <li><a href="#esophagectomy-in-the-elderly" id="toc-esophagectomy-in-the-elderly" class="nav-link active" data-scroll-target="#esophagectomy-in-the-elderly">Esophagectomy in the Elderly</a></li>
  <li><a href="#age-and-marginal-benefit-of-surgery-after-chemort" id="toc-age-and-marginal-benefit-of-surgery-after-chemort" class="nav-link" data-scroll-target="#age-and-marginal-benefit-of-surgery-after-chemort">Age and marginal benefit of surgery after ChemoRT</a></li>
  <li><a href="#frailty-and-complications-after-esophagectomy" id="toc-frailty-and-complications-after-esophagectomy" class="nav-link" data-scroll-target="#frailty-and-complications-after-esophagectomy">Frailty and complications after esophagectomy</a></li>
  <li><a href="#frailty-and-survival-after-esophagectomy" id="toc-frailty-and-survival-after-esophagectomy" class="nav-link" data-scroll-target="#frailty-and-survival-after-esophagectomy">Frailty and survival after esophagectomy</a></li>
  <li><a href="#retrospective-trimodality-vs-dcrt" id="toc-retrospective-trimodality-vs-dcrt" class="nav-link" data-scroll-target="#retrospective-trimodality-vs-dcrt">Retrospective Trimodality vs dCRT</a></li>
  <li><a href="#chemort-in-trimodality-eligible-patients" id="toc-chemort-in-trimodality-eligible-patients" class="nav-link" data-scroll-target="#chemort-in-trimodality-eligible-patients">ChemoRT in Trimodality-eligible patients</a></li>
  <li><a href="#active-surveillance" id="toc-active-surveillance" class="nav-link" data-scroll-target="#active-surveillance">Active Surveillance</a></li>
  <li><a href="#randomized-trials-of-trimodality-vs-dcrt" id="toc-randomized-trials-of-trimodality-vs-dcrt" class="nav-link" data-scroll-target="#randomized-trials-of-trimodality-vs-dcrt">Randomized trials of Trimodality vs dCRT</a></li>
  <li><a href="#reviews---trimodality-vs-dcrt" id="toc-reviews---trimodality-vs-dcrt" class="nav-link" data-scroll-target="#reviews---trimodality-vs-dcrt">Reviews - Trimodality vs dCRT</a></li>
  <li><a href="#esophagectomy-in-the-elderly-1" id="toc-esophagectomy-in-the-elderly-1" class="nav-link" data-scroll-target="#esophagectomy-in-the-elderly-1">Esophagectomy in the Elderly</a></li>
  <li><a href="#quality-of-life-after-esophagectomy" id="toc-quality-of-life-after-esophagectomy" class="nav-link" data-scroll-target="#quality-of-life-after-esophagectomy">Quality of life after esophagectomy</a></li>
  <li><a href="#chemort-in-trimodality-eligible-patients-1" id="toc-chemort-in-trimodality-eligible-patients-1" class="nav-link" data-scroll-target="#chemort-in-trimodality-eligible-patients-1">ChemoRT in Trimodality-eligible patients</a></li>
  <li><a href="#active-surveillance-1" id="toc-active-surveillance-1" class="nav-link" data-scroll-target="#active-surveillance-1">Active Surveillance</a></li>
  <li><a href="#randomized-trials-of-trimodality-vs-dcrt-1" id="toc-randomized-trials-of-trimodality-vs-dcrt-1" class="nav-link" data-scroll-target="#randomized-trials-of-trimodality-vs-dcrt-1">Randomized trials of Trimodality vs dCRT</a></li>
  <li><a href="#reviews---trimodality-vs-dcrt-1" id="toc-reviews---trimodality-vs-dcrt-1" class="nav-link" data-scroll-target="#reviews---trimodality-vs-dcrt-1">Reviews - Trimodality vs dCRT</a></li>
  </ul>
</nav>
    </div>
<!-- main -->
<main class="content" id="quarto-document-content">

<header id="title-block-header" class="quarto-title-block default">
<div class="quarto-title">
<h1 class="title">Esophageal Cancer Treatment Decisions</h1>
</div>



<div class="quarto-title-meta">

    
  
    
  </div>
  

</header>

<section id="esophagectomy-in-the-elderly" class="level1">
<h1>Esophagectomy in the Elderly</h1>
<p>Meta-analysis of studies <span class="citation" data-cites="baranov131">(<a href="#ref-baranov131" role="doc-biblioref">Baranov et al. 2021</a>)</span>: 90-day mortality 9% for those 75+ vs 3.9% in those &lt;75</p>
<p>Groningen: <span class="citation" data-cites="faiz986">(<a href="#ref-faiz986" role="doc-biblioref">Faiz et al. 2019</a>)</span> Esophageal SCCA: Age and co-morbidity wre associated with higher probability of cCRT</p>
<p>Metaanalysis of age and esophageal cancer treatment <span class="citation" data-cites="mantziari2104">(<a href="#ref-mantziari2104" role="doc-biblioref">Mantziari et al. 2021</a>)</span></p>
<p>Eindhoven cancer registry. Esohpagectomy 90=day mortality 7.1% for &lt;65 years, 8.7% for 65-74 years, and 15.4% for 75+</p>
</section>
<section id="age-and-marginal-benefit-of-surgery-after-chemort" class="level1">
<h1>Age and marginal benefit of surgery after ChemoRT</h1>
<p>NCDB <span class="citation" data-cites="jensendoac050">(<a href="#ref-jensendoac050" role="doc-biblioref">Jensen, Hammonds, and Haque 2022</a>)</span> compared survival with chemoradiation+Surgery vs chemoradiation alone and found a survival benefit to surgery, except for patients over age 80 with adenocarcinoma and patients with squamous cell carcinoma with Charson/Deyo 2 or 3+, in whom there was no survival advantage or detriment to surgery</p>
<p>NCDB <span class="citation" data-cites="farrow996">(<a href="#ref-farrow996" role="doc-biblioref">Farrow et al. 2021</a>)</span> Compared survival of stage II or III esophageal cancer in 17,495 patients, of whom 11,680 underwent esophagectomy and 5815 received chemoradiation. Survival after esophagectomy worsened with increasing age and decreased considerably after age 73. More use of dCRT after age 73. Survival benefit of surgery over chemoradiation in all ages, including octogenarians.</p>
<p>SEER <span class="citation" data-cites="lv8483">(<a href="#ref-lv8483" role="doc-biblioref">Lv et al. 2021</a>)</span> 1596 Elderly patients with esophageal cancer: 278 had surgery.&nbsp; Longer survival with trimodality therapy.</p>
<p>The perioperative period is when patients are at most risk of developing cardiopulmonary complications with an operative mortality rate of 13.4% in those who are between 70–79 years old and 19.9% in those over the age of 80 (7,8).</p>
<p>Operative mortality after esophagectomy in those over age 80 is 19.9% (vs 8.8% under age 90) from National Inpatient Sample data <span class="citation" data-cites="finlayson729">(<a href="#ref-finlayson729" role="doc-biblioref">Finlayson, Fan, and Birkmeyer 2007</a>)</span></p>
</section>
<section id="frailty-and-complications-after-esophagectomy" class="level1">
<h1>Frailty and complications after esophagectomy</h1>
<p>Dublin <span class="citation" data-cites="elliott822b">(<a href="#ref-elliott822b" role="doc-biblioref"><strong>elliott822b?</strong></a>)</span> Sarcopenia present in XX % and was associated with increased risk of perioperative complications. Sarcopenia was not associated with hospital mortality, which was 1%. Sarcopenia was associated with reduced 5-year survival, as was loss of muscle mass during neoadjuvant therapy.</p>
<p>Review of sarcopenia and outcomes after GI cancer surgery <span class="citation" data-cites="su82">(<a href="#ref-su82" role="doc-biblioref">Su et al. 2019</a>)</span> Sarcopenia associated with increased risk of postoperative complications and decreased survival after esophagectomy.</p>
<p>Negative impact of muscle wasting after chemotherapy followed by surgery <span class="citation" data-cites="mayanagi3741">(<a href="#ref-mayanagi3741" role="doc-biblioref">Mayanagi et al. 2017</a>)</span> 66 pts</p>
<p>Sarcopenia as a predictor of pulmonary complications after esophagectomy for thoracic esophageal cancer <span class="citation" data-cites="nishigori678">(<a href="#ref-nishigori678" role="doc-biblioref">Nishigori et al. 2016</a>)</span></p>
</section>
<section id="frailty-and-survival-after-esophagectomy" class="level1">
<h1>Frailty and survival after esophagectomy</h1>
<p>Esophageal cancer 341 patients, of whom 170 over age 65 <span class="citation" data-cites="nakashima1100">(<a href="#ref-nakashima1100" role="doc-biblioref">Nakashima et al. 2018</a>)</span> sarcopenia predicted short term outcome and survival, but only in patients over age 65</p>
<p>Vienna: 130 patients with esophageal cancer getting neoadjuvant chemotherapy, of whom 80 had sarcopenia <span class="citation" data-cites="paireder478">(<a href="#ref-paireder478" role="doc-biblioref">Paireder et al. 2017</a>)</span> Sarcopenia associated with shorter survival (HR 1.72)</p>
<p>200 patients with esophageal cancer of whom 130 (65%) had sarcopenia <span class="citation" data-cites="tamandl1359">(<a href="#ref-tamandl1359" role="doc-biblioref">Tamandl et al. 2016</a>)</span> patients with sarcopenia had decreased survival.</p>
<p>Sarcopenia associated with decreased survival (p=0.035) in node-negative esophageal cancer patients after surgery (but not with node-positive).<span class="citation" data-cites="harada7">(<a href="#ref-harada7" role="doc-biblioref">Harada et al. 2015</a>)</span></p>
<p>CROSS: Sarcopenia/Muscle Mass is not a Prognostic Factor for Short- and Long-Term Outcome After Esophagectomy for Cancer <span class="citation" data-cites="grotenhuis2698">(<a href="#ref-grotenhuis2698" role="doc-biblioref">Grotenhuis et al. 2016</a>)</span></p>
</section>
<section id="retrospective-trimodality-vs-dcrt" class="level1">
<h1>Retrospective Trimodality vs dCRT</h1>
<p>Italy <span class="citation" data-cites="castoro1375">(<a href="#ref-castoro1375" role="doc-biblioref">Castoro et al. 2013</a>)</span> Squamous cell 77 patients over 16 years. Comparable survival with dCRT vs Trimodality even after correcting for propensity score</p>
<p>Dutch<span class="citation" data-cites="faiz986">(<a href="#ref-faiz986" role="doc-biblioref">Faiz et al. 2019</a>)</span> Factors accounting for choice of dCRT vs Trimodality: age &gt;75, hypertension+diabetes, CV+pulmonary. Adenocarcinoma: better survival with Trimodality. SCCA: Age &gt;75 or &gt;2 comorbidities overall survival was comparable between groups.</p>
<p>Taiwan <span class="citation" data-cites="wang255">(<a href="#ref-wang255" role="doc-biblioref">Wang et al. 2019</a>)</span> 5832 patients with SCC: Trimodality in 1754 and dCRT in 4078. Survival at 3 years 41% with trimodality vs 17% with dCRT</p>
<p>MDACC <span class="citation" data-cites="zhou1207">(<a href="#ref-zhou1207" role="doc-biblioref">Zhou et al. 2021</a>)</span> Squamous cell: 143 Trimodality-eligible patients: 60 had trimodality therapy and 83 had chemoRT. Longer survival in trimodality group (77 vs 33 months). For those with a complete clinical response, trimodality resulted in 123 moths survival vs 55 months with dCRT. Trimodality therapy was not associated with longer overall survival but predicted recurrence-free survival.</p>
<p>UK <span class="citation" data-cites="hategan612">(<a href="#ref-hategan612" role="doc-biblioref">Hategan et al. 2015</a>)</span> 102 patients with esophageal cancer: 55 trimodality and 47 dCRT. Longer survival with trimodality</p>
</section>
<section id="chemort-in-trimodality-eligible-patients" class="level1">
<h1>ChemoRT in Trimodality-eligible patients</h1>
<p>MDACC <span class="citation" data-cites="taketa300">(<a href="#ref-taketa300" role="doc-biblioref">Taketa et al. 2012</a>)</span> 662 patient eligible for trimodality therapy received chemoradiation. 61 patients (9.8%) refused surgery. &nbsp;5-year overall survival 58% and relapse-free survival 35%. 13 patients developed localized recurrences, of whom 12 underwent salvage esophagectomy.</p>
<p>MDCAA <span class="citation" data-cites="taketa95">(<a href="#ref-taketa95" role="doc-biblioref">Taketa et al. 2013</a>)</span></p>
</section>
<section id="active-surveillance" class="level1">
<h1>Active Surveillance</h1>
<p>Dutch preSano <span class="citation" data-cites="noordman965">(<a href="#ref-noordman965" role="doc-biblioref">Noordman, Spaander, et al. 2018</a>)</span></p>
<p>SANO randomized trial <span class="citation" data-cites="noordman142">(<a href="#ref-noordman142" role="doc-biblioref">Noordman, Wijnhoven, et al. 2018</a>)</span></p>
<p>Editorial <span class="citation" data-cites="vanderwilk462">(<a href="#ref-vanderwilk462" role="doc-biblioref">van der Wilk et al. 2019</a>)</span></p>
</section>
<section id="randomized-trials-of-trimodality-vs-dcrt" class="level1">
<h1>Randomized trials of Trimodality vs dCRT</h1>
<p>FFCD 9012 <span class="citation" data-cites="bedenne1160">(<a href="#ref-bedenne1160" role="doc-biblioref">Bedenne et al. 2007</a>)</span> German Trial <span class="citation" data-cites="stahl2310">(<a href="#ref-stahl2310" role="doc-biblioref">Stahl et al. 2005</a>)</span></p>
</section>
<section id="reviews---trimodality-vs-dcrt" class="level1">
<h1>Reviews - Trimodality vs dCRT</h1>
<p><span class="citation" data-cites="vellayappanCD010511">(<a href="#ref-vellayappanCD010511" role="doc-biblioref">Vellayappan et al. 2017</a>)</span> Addition of surgery to dCRT adds little or benefit for patients with squamous cell carcinoma. Authors could not determine whether there was benefit of the addition of surgery for adenocarcinoma and GE junction cancers.</p>
<p><span class="citation" data-cites="voeten1271">(<a href="#ref-voeten1271" role="doc-biblioref">Voeten et al. 2019</a>)</span> No clear advantage of trimodality therapy over dCRT</p>
</section>
<section id="esophagectomy-in-the-elderly-1" class="level1">
<h1>Esophagectomy in the Elderly</h1>
<p>Meta-analysis of studies <span class="citation" data-cites="baranov131">(<a href="#ref-baranov131" role="doc-biblioref">Baranov et al. 2021</a>)</span>: 90-day mortality 9% for those 75+ vs 3.9% in those &lt;75</p>
<p>Groningen: <span class="citation" data-cites="faiz986">(<a href="#ref-faiz986" role="doc-biblioref">Faiz et al. 2019</a>)</span> Esophageal SCCA: Age and co-morbidity wre associated with higher probability of cCRT</p>
<p>Metaanalysis of age and esophageal cancer treatment <span class="citation" data-cites="mantziari2104">(<a href="#ref-mantziari2104" role="doc-biblioref">Mantziari et al. 2021</a>)</span></p>
</section>
<section id="quality-of-life-after-esophagectomy" class="level1">
<h1>Quality of life after esophagectomy</h1>
<p>Esophagectomy is accompanied by profound alterations in quality of life (reviewed in taioli 377).</p>
<p>The EORTC quality of life questionnaire (QLQ-C30) incorporates a 18-question quality of life scale specific for esophageal disease (OES-18) {Aaronson,&nbsp;#1661;Blazeby,&nbsp;#1662;Blazeby,&nbsp; #1663}.</p>
<p>FACIT {Webster, 2003 #2011}</p>
<p>Cancer FACIT {Cella, 1993 #2015}</p>
</section>
<section id="chemort-in-trimodality-eligible-patients-1" class="level1">
<h1>ChemoRT in Trimodality-eligible patients</h1>
<p>MDACC <span class="citation" data-cites="taketa300">(<a href="#ref-taketa300" role="doc-biblioref">Taketa et al. 2012</a>)</span> 662 patient eligible for trimodality therapy received chemoradiation. 61 patients (9.8%) refused surgery. &nbsp;5-year overall survival 58% and relapse-free survival 35%. 13 patients developed localized recurrences, of whom 12 underwent salvage esophagectomy.</p>
<p>MDCAA <span class="citation" data-cites="taketa95">(<a href="#ref-taketa95" role="doc-biblioref">Taketa et al. 2013</a>)</span></p>
</section>
<section id="active-surveillance-1" class="level1">
<h1>Active Surveillance</h1>
<p>Dutch preSano <span class="citation" data-cites="noordman965">(<a href="#ref-noordman965" role="doc-biblioref">Noordman, Spaander, et al. 2018</a>)</span></p>
<p>SANO randomized trial <span class="citation" data-cites="noordman142">(<a href="#ref-noordman142" role="doc-biblioref">Noordman, Wijnhoven, et al. 2018</a>)</span></p>
<p>Editorial <span class="citation" data-cites="vanderwilk462">(<a href="#ref-vanderwilk462" role="doc-biblioref">van der Wilk et al. 2019</a>)</span></p>
</section>
<section id="randomized-trials-of-trimodality-vs-dcrt-1" class="level1">
<h1>Randomized trials of Trimodality vs dCRT</h1>
<p>FFCD 9012 <span class="citation" data-cites="bedenne1160">(<a href="#ref-bedenne1160" role="doc-biblioref">Bedenne et al. 2007</a>)</span> German Trial <span class="citation" data-cites="stahl2310">(<a href="#ref-stahl2310" role="doc-biblioref">Stahl et al. 2005</a>)</span></p>
</section>
<section id="reviews---trimodality-vs-dcrt-1" class="level1">
<h1>Reviews - Trimodality vs dCRT</h1>
<p><span class="citation" data-cites="vellayappanCD010511">(<a href="#ref-vellayappanCD010511" role="doc-biblioref">Vellayappan et al. 2017</a>)</span> Addition of surgery to dCRT adds little or benefit for patients with squamous cell carcinoma. Authors could not determine whether there was benefit of the addition of surgery for adenocarcinoma and GE junction cancers.</p>
<p><span class="citation" data-cites="voeten1271">(<a href="#ref-voeten1271" role="doc-biblioref">Voeten et al. 2019</a>)</span> No clear advantage of trimodality therapy over dCRT</p>



</section>

<div id="quarto-appendix" class="default"><section class="quarto-appendix-contents" role="doc-bibliography"><h2 class="anchored quarto-appendix-heading">References</h2><div id="refs" class="references csl-bib-body hanging-indent" role="doc-bibliography">
<div id="ref-baranov131" class="csl-entry" role="doc-biblioentry">
Baranov, Nikolaj S., Cettela Slootmans, Frans van Workum, Bastiaan R. Klarenbeek, Yvonne Schoon, and Camiel Rosman. 2021. <span>“Outcomes of Curative Esophageal Cancer Surgery in Elderly: <span>A</span> Meta-Analysis.”</span> <em>World Journal of Gastrointestinal Oncology</em> 13 (2): 131–46. <a href="https://doi.org/10.4251/wjgo.v13.i2.131">https://doi.org/10.4251/wjgo.v13.i2.131</a>.
</div>
<div id="ref-bedenne1160" class="csl-entry" role="doc-biblioentry">
Bedenne, Laurent, Pierre Michel, Olivier Bouché, Chantal Milan, Christophe Mariette, Thierry Conroy, Denis Pezet, et al. 2007. <span>“Chemoradiation Followed by Surgery Compared with Chemoradiation Alone in Squamous Cancer of the Esophagus: <span>FFCD</span> 9102.”</span> <em>Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology</em> 25 (10): 1160–68. <a href="https://doi.org/10.1200/JCO.2005.04.7118">https://doi.org/10.1200/JCO.2005.04.7118</a>.
</div>
<div id="ref-castoro1375" class="csl-entry" role="doc-biblioentry">
Castoro, Carlo, Marco Scarpa, Matteo Cagol, Rita Alfieri, Alberto Ruol, Francesco Cavallin, Silvia Michieletto, et al. 2013. <span>“Complete Clinical Response After Neoadjuvant Chemoradiotherapy for Squamous Cell Cancer of the Thoracic Oesophagus: Is Surgery Always Necessary?”</span> <em>Journal of Gastrointestinal Surgery: Official Journal of the Society for Surgery of the Alimentary Tract</em> 17 (8): 1375–81. <a href="https://doi.org/10.1007/s11605-013-2269-3">https://doi.org/10.1007/s11605-013-2269-3</a>.
</div>
<div id="ref-faiz986" class="csl-entry" role="doc-biblioentry">
Faiz, Z., M. van Putten, R. H. A. Verhoeven, J. W. van Sandick, G. a. P. Nieuwenhuijzen, M. J. C. van der Sangen, V. E. P. P. Lemmens, B. P. L. Wijnhoven, and J. T. M. Plukker. 2019. <span>“Impact of <span>Age</span> and <span>Comorbidity</span> on <span>Choice</span> and <span>Outcome</span> of <span>Two Different Treatment Options</span> for <span>Patients</span> with <span>Potentially Curable Esophageal Cancer</span>.”</span> <em>Annals of Surgical Oncology</em> 26 (4): 986–95. <a href="https://doi.org/10.1245/s10434-019-07181-6">https://doi.org/10.1245/s10434-019-07181-6</a>.
</div>
<div id="ref-farrow996" class="csl-entry" role="doc-biblioentry">
Farrow, Norma E., Vignesh Raman, Oliver K. Jawitz, Soraya L. Voigt, Betty C. Tong, David H. Harpole, and Thomas A. D’Amico. 2021. <span>“Impact of <span>Age</span> on <span>Surgical Outcomes</span> for <span>Locally Advanced Esophageal Cancer</span>.”</span> <em>The Annals of Thoracic Surgery</em> 111 (3): 996–1003. <a href="https://doi.org/10.1016/j.athoracsur.2020.06.055">https://doi.org/10.1016/j.athoracsur.2020.06.055</a>.
</div>
<div id="ref-finlayson729" class="csl-entry" role="doc-biblioentry">
Finlayson, Emily, Zhaohui Fan, and John D. Birkmeyer. 2007. <span>“Outcomes in Octogenarians Undergoing High-Risk Cancer Operation: A National Study.”</span> <em>Journal of the American College of Surgeons</em> 205 (6): 729–34. <a href="https://doi.org/10.1016/j.jamcollsurg.2007.06.307">https://doi.org/10.1016/j.jamcollsurg.2007.06.307</a>.
</div>
<div id="ref-grotenhuis2698" class="csl-entry" role="doc-biblioentry">
Grotenhuis, Brechtje A., Joël Shapiro, Stefan van Adrichem, Marianne de Vries, Marcel Koek, Bas P. L. Wijnhoven, and J. Jan B. van Lanschot. 2016. <span>“Sarcopenia/<span>Muscle Mass</span> Is Not a <span>Prognostic Factor</span> for <span>Short-</span> and <span>Long-Term Outcome After Esophagectomy</span> for <span>Cancer</span>.”</span> <em>World Journal of Surgery</em> 40 (11): 2698–2704. <a href="https://doi.org/10.1007/s00268-016-3603-1">https://doi.org/10.1007/s00268-016-3603-1</a>.
</div>
<div id="ref-harada7" class="csl-entry" role="doc-biblioentry">
Harada, K, S Ida, Y Baba, T Ishimoto, K Kosumi, R Tokunaga, D Izumi, et al. 2015. <span>“Prognostic and Clinical Impact of Sarcopenia in Esophageal Squamous Cell Carcinoma,”</span> 7.
</div>
<div id="ref-hategan612" class="csl-entry" role="doc-biblioentry">
Hategan, M., N. Cook, S. Prewett, A. Hindmarsh, W. Qian, and D. Gilligan. 2015. <span>“Trimodality Therapy and Definitive Chemoradiotherapy for Esophageal Cancer: A Single-Center Experience and Review of the Literature.”</span> <em>Diseases of the Esophagus: Official Journal of the International Society for Diseases of the Esophagus</em> 28 (7): 612–18. <a href="https://doi.org/10.1111/dote.12242">https://doi.org/10.1111/dote.12242</a>.
</div>
<div id="ref-jensendoac050" class="csl-entry" role="doc-biblioentry">
Jensen, Garrett L., Kendall P. Hammonds, and Waqar Haque. 2022. <span>“Neoadjuvant Versus Definitive Chemoradiation in Locally Advanced Esophageal Cancer for Patients of Advanced Age or Significant Comorbidities.”</span> <em>Diseases of the Esophagus: Official Journal of the International Society for Diseases of the Esophagus</em>, July, doac050. <a href="https://doi.org/10.1093/dote/doac050">https://doi.org/10.1093/dote/doac050</a>.
</div>
<div id="ref-lv8483" class="csl-entry" role="doc-biblioentry">
Lv, Hao, Ce Chao, Bin Wang, Zhigang Wang, Yongxiang Qian, and Xiaoying Zhang. 2021. <span>“The Effect of Surgery Plus Chemoradiotherapy on Survival of Elderly Patients with Stage II-III Esophageal Cancer: A <span class="nocase">SEER-based</span> Demographic Analysis.”</span> <em>Cancer Medicine</em> 10 (23): 8483–96. <a href="https://doi.org/10.1002/cam4.4352">https://doi.org/10.1002/cam4.4352</a>.
</div>
<div id="ref-mantziari2104" class="csl-entry" role="doc-biblioentry">
Mantziari, Styliani, Hugo Teixeira Farinha, Vianney Bouygues, Jean-Charles Vignal, Yannick Deswysen, Nicolas Demartines, Markus Schäfer, and Guillaume Piessen. 2021. <span>“Esophageal <span>Cancer</span> in <span>Elderly Patients</span>, <span>Current Treatment Options</span> and <span>Outcomes</span>; <span>A Systematic Review</span> and <span>Pooled Analysis</span>.”</span> <em>Cancers</em> 13 (9): 2104. <a href="https://doi.org/10.3390/cancers13092104">https://doi.org/10.3390/cancers13092104</a>.
</div>
<div id="ref-mayanagi3741" class="csl-entry" role="doc-biblioentry">
Mayanagi, Shuhei, Yasuhiro Tsubosa, Katsuhiro Omae, Masahiro Niihara, Tsuneyuki Uchida, Takahiro Tsushima, Tomoya Yokota, Hiroshi Sato, Tateaki Naito, and Hirofumi Yasui. 2017. <span>“Negative <span>Impact</span> of <span>Skeletal Muscle Wasting After Neoadjuvant Chemotherapy Followed</span> by <span>Surgery</span> on <span>Survival</span> for <span>Patients</span> with <span>Thoracic Esophageal Cancer</span>.”</span> <em>Annals of Surgical Oncology</em> 24 (12): 3741–47. <a href="https://doi.org/10.1245/s10434-017-6020-2">https://doi.org/10.1245/s10434-017-6020-2</a>.
</div>
<div id="ref-nakashima1100" class="csl-entry" role="doc-biblioentry">
Nakashima, Yuichiro, Hiroshi Saeki, Ryota Nakanishi, Masahiko Sugiyama, Junji Kurashige, Eiji Oki, and Yoshihiko Maehara. 2018. <span>“Assessment of <span>Sarcopenia</span> as a <span>Predictor</span> of <span>Poor Outcomes After Esophagectomy</span> in <span>Elderly Patients With Esophageal Cancer</span>.”</span> <em>Annals of Surgery</em> 267 (6): 1100–1104. <a href="https://doi.org/10.1097/SLA.0000000000002252">https://doi.org/10.1097/SLA.0000000000002252</a>.
</div>
<div id="ref-nishigori678" class="csl-entry" role="doc-biblioentry">
Nishigori, T., H. Okabe, E. Tanaka, S. Tsunoda, S. Hisamori, and Y. Sakai. 2016. <span>“Sarcopenia as a Predictor of Pulmonary Complications After Esophagectomy for Thoracic Esophageal Cancer.”</span> Journal {{Article}}. <em>J Surg Oncol</em> 113 (6): 678–84. <a href="https://doi.org/10.1002/jso.24214">https://doi.org/10.1002/jso.24214</a>.
</div>
<div id="ref-noordman965" class="csl-entry" role="doc-biblioentry">
Noordman, Bo Jan, Manon C. W. Spaander, Roelf Valkema, Bas P. L. Wijnhoven, Mark I. van Berge Henegouwen, Joël Shapiro, Katharina Biermann, et al. 2018. <span>“Detection of Residual Disease After Neoadjuvant Chemoradiotherapy for Oesophageal Cancer (<span class="nocase">preSANO</span>): A Prospective Multicentre, Diagnostic Cohort Study.”</span> <em>The Lancet. Oncology</em> 19 (7): 965–74. <a href="https://doi.org/10.1016/S1470-2045(18)30201-8">https://doi.org/10.1016/S1470-2045(18)30201-8</a>.
</div>
<div id="ref-noordman142" class="csl-entry" role="doc-biblioentry">
Noordman, Bo Jan, Bas P. L. Wijnhoven, Sjoerd M. Lagarde, Jurjen J. Boonstra, Peter Paul L. O. Coene, Jan Willem T. Dekker, Michael Doukas, et al. 2018. <span>“Neoadjuvant Chemoradiotherapy Plus Surgery Versus Active Surveillance for Oesophageal Cancer: A Stepped-Wedge Cluster Randomised Trial.”</span> <em>BMC Cancer</em> 18 (1): 142. <a href="https://doi.org/10.1186/s12885-018-4034-1">https://doi.org/10.1186/s12885-018-4034-1</a>.
</div>
<div id="ref-paireder478" class="csl-entry" role="doc-biblioentry">
Paireder, M., R. Asari, I. Kristo, E. Rieder, D. Tamandl, A. Ba-Ssalamah, and S. F. Schoppmann. 2017. <span>“Impact of Sarcopenia on Outcome in Patients with Esophageal Resection Following Neoadjuvant Chemotherapy for Esophageal Cancer.”</span> <em>European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology</em> 43 (2): 478–84. <a href="https://doi.org/10.1016/j.ejso.2016.11.015">https://doi.org/10.1016/j.ejso.2016.11.015</a>.
</div>
<div id="ref-stahl2310" class="csl-entry" role="doc-biblioentry">
Stahl, Michael, Martin Stuschke, Nils Lehmann, Hans-Joachim Meyer, Martin K. Walz, Siegfried Seeber, Bodo Klump, et al. 2005. <span>“Chemoradiation with and Without Surgery in Patients with Locally Advanced Squamous Cell Carcinoma of the Esophagus.”</span> <em>Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology</em> 23 (10): 2310–17. <a href="https://doi.org/10.1200/JCO.2005.00.034">https://doi.org/10.1200/JCO.2005.00.034</a>.
</div>
<div id="ref-su82" class="csl-entry" role="doc-biblioentry">
Su, Huaiying, Junxian Ruan, Tianfeng Chen, Enyi Lin, and Lijing Shi. 2019. <span>“<span class="nocase">CT-assessed</span> Sarcopenia Is a Predictive Factor for Both Long-Term and Short-Term Outcomes in Gastrointestinal Oncology Patients: A Systematic Review and Meta-Analysis.”</span> <em>Cancer Imaging: The Official Publication of the International Cancer Imaging Society</em> 19 (1): 82. <a href="https://doi.org/10.1186/s40644-019-0270-0">https://doi.org/10.1186/s40644-019-0270-0</a>.
</div>
<div id="ref-taketa300" class="csl-entry" role="doc-biblioentry">
Taketa, Takashi, Arlene M. Correa, Akihiro Suzuki, Mariela A. Blum, Pamela Chien, Jeffrey H. Lee, James Welsh, et al. 2012. <span>“Outcome of Trimodality-Eligible Esophagogastric Cancer Patients Who Declined Surgery After Preoperative Chemoradiation.”</span> Journal {{Article}}. <em>Oncology</em> 83 (5): 300–304. <a href="https://doi.org/10.1159/000341353">https://doi.org/10.1159/000341353</a>.
</div>
<div id="ref-taketa95" class="csl-entry" role="doc-biblioentry">
Taketa, Takashi, Lianchun Xiao, Kazuki Sudo, Akihiro Suzuki, Roopma Wadhwa, Mariela A. Blum, Jeffrey H. Lee, et al. 2013. <span>“Propensity-Based Matching Between Esophagogastric Cancer Patients Who Had Surgery and Who Declined Surgery After Preoperative Chemoradiation.”</span> <em>Oncology</em> 85 (2): 95–99. <a href="https://doi.org/10.1159/000351999">https://doi.org/10.1159/000351999</a>.
</div>
<div id="ref-tamandl1359" class="csl-entry" role="doc-biblioentry">
Tamandl, Dietmar, Matthias Paireder, Reza Asari, Pascal A. Baltzer, Sebastian F. Schoppmann, and Ahmed Ba-Ssalamah. 2016. <span>“Markers of Sarcopenia Quantified by Computed Tomography Predict Adverse Long-Term Outcome in Patients with Resected Oesophageal or Gastro-Oesophageal Junction Cancer.”</span> <em>European Radiology</em> 26 (5): 1359–67. <a href="https://doi.org/10.1007/s00330-015-3963-1">https://doi.org/10.1007/s00330-015-3963-1</a>.
</div>
<div id="ref-vanderwilk462" class="csl-entry" role="doc-biblioentry">
van der Wilk, Berend Jan, Ben M. Eyck, Manon C. W. Spaander, Roelf Valkema, Sjoerd M. Lagarde, Bas P. L. Wijnhoven, and J. Jan B. van Lanschot. 2019. <span>“Towards an <span>Organ-Sparing Approach</span> for <span>Locally Advanced Esophageal Cancer</span>.”</span> <em>Digestive Surgery</em> 36 (6): 462–69. <a href="https://doi.org/10.1159/000493435">https://doi.org/10.1159/000493435</a>.
</div>
<div id="ref-vellayappanCD010511" class="csl-entry" role="doc-biblioentry">
Vellayappan, Balamurugan A., Yu Yang Soon, Geoffrey Y. Ku, Cheng Nang Leong, Jiade J. Lu, and Jeremy Cs Tey. 2017. <span>“Chemoradiotherapy Versus Chemoradiotherapy Plus Surgery for Esophageal Cancer.”</span> <em>The Cochrane Database of Systematic Reviews</em> 8 (August): CD010511. <a href="https://doi.org/10.1002/14651858.CD010511.pub2">https://doi.org/10.1002/14651858.CD010511.pub2</a>.
</div>
<div id="ref-voeten1271" class="csl-entry" role="doc-biblioentry">
Voeten, Daan M., Chantal M. den Bakker, David J. Heineman, Johannes C. F. Ket, Freek Daams, and Donald L. van der Peet. 2019. <span>“Definitive <span>Chemoradiotherapy Versus Trimodality Therapy</span> for <span>Resectable Oesophageal Carcinoma</span>: <span class="nocase">Meta-analyses</span> and <span>Systematic Review</span> of <span>Literature</span>.”</span> <em>World Journal of Surgery</em> 43 (5): 1271–85. <a href="https://doi.org/10.1007/s00268-018-04901-z">https://doi.org/10.1007/s00268-018-04901-z</a>.
</div>
<div id="ref-wang255" class="csl-entry" role="doc-biblioentry">
Wang, B.-Y., S.-C. Wu, H.-C. Chen, W.-H. Hung, C.-H. Lin, C.-L. Huang, and H.-S. Chen. 2019. <span>“Survival After Neoadjuvant Chemoradiotherapy and Oesophagectomy Versus Definitive Chemoradiotherapy for Patients with Oesophageal Squamous Cell Carcinoma.”</span> <em>The British Journal of Surgery</em> 106 (3): 255–62. <a href="https://doi.org/10.1002/bjs.11004">https://doi.org/10.1002/bjs.11004</a>.
</div>
<div id="ref-zhou1207" class="csl-entry" role="doc-biblioentry">
Zhou, N., K. G. Mitchell, E. M. Corsini, V. T. T. Truong, M. B. Antonoff, R. J. Mehran, R. Rajaram, et al. 2021. <span>“Analysis of Trimodal and Bimodal Therapy in a Selective-Surgery Paradigm for Locally Advanced Oesophageal Squamous Cell Carcinoma.”</span> <em>The British Journal of Surgery</em> 108 (10): 1207–15. <a href="https://doi.org/10.1093/bjs/znab162">https://doi.org/10.1093/bjs/znab162</a>.
</div>
</div></section></div></main> <!-- /main -->
<script id="quarto-html-after-body" type="application/javascript">
window.document.addEventListener("DOMContentLoaded", function (event) {
  const toggleBodyColorMode = (bsSheetEl) => {
    const mode = bsSheetEl.getAttribute("data-mode");
    const bodyEl = window.document.querySelector("body");
    if (mode === "dark") {
      bodyEl.classList.add("quarto-dark");
      bodyEl.classList.remove("quarto-light");
    } else {
      bodyEl.classList.add("quarto-light");
      bodyEl.classList.remove("quarto-dark");
    }
  }
  const toggleBodyColorPrimary = () => {
    const bsSheetEl = window.document.querySelector("link#quarto-bootstrap");
    if (bsSheetEl) {
      toggleBodyColorMode(bsSheetEl);
    }
  }
  toggleBodyColorPrimary();  
  const icon = "";
  const anchorJS = new window.AnchorJS();
  anchorJS.options = {
    placement: 'right',
    icon: icon
  };
  anchorJS.add('.anchored');
  const clipboard = new window.ClipboardJS('.code-copy-button', {
    target: function(trigger) {
      return trigger.previousElementSibling;
    }
  });
  clipboard.on('success', function(e) {
    // button target
    const button = e.trigger;
    // don't keep focus
    button.blur();
    // flash "checked"
    button.classList.add('code-copy-button-checked');
    var currentTitle = button.getAttribute("title");
    button.setAttribute("title", "Copied!");
    let tooltip;
    if (window.bootstrap) {
      button.setAttribute("data-bs-toggle", "tooltip");
      button.setAttribute("data-bs-placement", "left");
      button.setAttribute("data-bs-title", "Copied!");
      tooltip = new bootstrap.Tooltip(button, 
        { trigger: "manual", 
          customClass: "code-copy-button-tooltip",
          offset: [0, -8]});
      tooltip.show();    
    }
    setTimeout(function() {
      if (tooltip) {
        tooltip.hide();
        button.removeAttribute("data-bs-title");
        button.removeAttribute("data-bs-toggle");
        button.removeAttribute("data-bs-placement");
      }
      button.setAttribute("title", currentTitle);
      button.classList.remove('code-copy-button-checked');
    }, 1000);
    // clear code selection
    e.clearSelection();
  });
  function tippyHover(el, contentFn) {
    const config = {
      allowHTML: true,
      content: contentFn,
      maxWidth: 500,
      delay: 100,
      arrow: false,
      appendTo: function(el) {
          return el.parentElement;
      },
      interactive: true,
      interactiveBorder: 10,
      theme: 'quarto',
      placement: 'bottom-start'
    };
    window.tippy(el, config); 
  }
  const noterefs = window.document.querySelectorAll('a[role="doc-noteref"]');
  for (var i=0; i<noterefs.length; i++) {
    const ref = noterefs[i];
    tippyHover(ref, function() {
      // use id or data attribute instead here
      let href = ref.getAttribute('data-footnote-href') || ref.getAttribute('href');
      try { href = new URL(href).hash; } catch {}
      const id = href.replace(/^#\/?/, "");
      const note = window.document.getElementById(id);
      return note.innerHTML;
    });
  }
  const findCites = (el) => {
    const parentEl = el.parentElement;
    if (parentEl) {
      const cites = parentEl.dataset.cites;
      if (cites) {
        return {
          el,
          cites: cites.split(' ')
        };
      } else {
        return findCites(el.parentElement)
      }
    } else {
      return undefined;
    }
  };
  var bibliorefs = window.document.querySelectorAll('a[role="doc-biblioref"]');
  for (var i=0; i<bibliorefs.length; i++) {
    const ref = bibliorefs[i];
    const citeInfo = findCites(ref);
    if (citeInfo) {
      tippyHover(citeInfo.el, function() {
        var popup = window.document.createElement('div');
        citeInfo.cites.forEach(function(cite) {
          var citeDiv = window.document.createElement('div');
          citeDiv.classList.add('hanging-indent');
          citeDiv.classList.add('csl-entry');
          var biblioDiv = window.document.getElementById('ref-' + cite);
          if (biblioDiv) {
            citeDiv.innerHTML = biblioDiv.innerHTML;
          }
          popup.appendChild(citeDiv);
        });
        return popup.innerHTML;
      });
    }
  }
});
</script>
</div> <!-- /content -->



</body></html>